These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 30706452)

  • 1. Serum cell-free DNA levels are a useful marker for extramammary Paget disease.
    Mijiddorj T; Kajihara I; Tasaki Y; Otsuka-Maeda S; Sakamoto R; Sawamura S; Kanazawa-Yamada S; Egashira S; Inoue K; Makino K; Miyashita A; Aoi J; Igata T; Makino T; Masuguchi S; Fukushima S; Jinnin M; Morinaga J; Ikeda T; Ihn H
    Br J Dermatol; 2019 Sep; 181(3):505-511. PubMed ID: 30706452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum cytokeratin 19 fragment 21-1 and carcinoembryonic antigen combination assay as a biomarker of tumour progression and treatment response in extramammary Paget disease.
    Nakamura Y; Tanese K; Hirai I; Amagai M; Kawakami Y; Funakoshi T
    Br J Dermatol; 2019 Sep; 181(3):535-543. PubMed ID: 30791097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cytokeratin 19 fragment 21-1 is a useful tumor marker for the assessment of extramammary Paget's disease.
    Kato J; Sumikawa Y; Hida T; Kamiya T; Horimoto K; Kamiya S; Sato S; Takahashi H; Sawada M; Yamashita T
    J Dermatol; 2017 Jun; 44(6):666-670. PubMed ID: 28150330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-155, a potential serum marker of extramammary Paget's disease.
    Guo H; Qi RQ; Sheng J; Liu C; Ma H; Wang HX; Li JH; Gao XH; Wan YS; Chen HD
    BMC Cancer; 2018 Nov; 18(1):1078. PubMed ID: 30458743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic landscape of circulating tumour DNA in metastatic extramammary Paget's disease.
    Sawamura S; Mijiddorj Myangat T; Kajihara I; Tanaka K; Ide M; Sakamoto R; Otsuka-Maeda S; Kanemaru H; Nishimura Y; Kanazawa-Yamada S; Kashiwada-Nakamura K; Honda N; Makino K; Aoi J; Igata T; Makino T; Masuguchi S; Fukushima S; Ihn H
    Exp Dermatol; 2022 Mar; 31(3):341-348. PubMed ID: 34676917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined serum carcinoembryonic antigen and cytokeratin 19 fragment levels provide a sensitive biomarker for lymph node metastasis in extramammary Paget's disease.
    Kato H; Nakamura M; Watanabe S; Oda T; Morita A
    J Dermatol; 2020 Jul; 47(7):763-769. PubMed ID: 32415799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring serum cytokeratin 19 fragment 21-1 to determine the efficacy of docetaxel chemotherapy in advanced extramammary Paget's disease.
    Onishi M; Maeda F; Akasaka T; Amano H
    J Dermatol; 2019 Mar; 46(3):e83-e84. PubMed ID: 30194782
    [No Abstract]   [Full Text] [Related]  

  • 8. RANKL expression is a useful marker for differentiation of pagetoid squamous cell carcinoma in situ from extramammary Paget disease.
    Fujimura T; Kambayashi Y; Kakizaki A; Furudate S; Aiba S
    J Cutan Pathol; 2016 Sep; 43(9):772-5. PubMed ID: 27251225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Cytokeratin 18 as a Metastatic and Therapeutic Marker for Extramammary Paget's Disease.
    Urano-Takaoka M; Sumida H; Miyagawa T; Awaji K; Nagai K; Omatsu J; Miyake T; Sato S
    Acta Derm Venereol; 2022 Jan; 102():adv00636. PubMed ID: 34904690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy may be more appropriate for ERBB2 low-expressing extramammary paget's disease patients: a prognosis analysis and exploration of targeted therapy and immunotherapy of extramammary paget's disease patients.
    Yang J; Chen Y; Zhang X; Tong Z; Weng S; Zhu N; Yuan Y
    Cancer Immunol Immunother; 2024 Oct; 73(12):252. PubMed ID: 39358617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of immunohistochemistry in discriminating primary from secondary extramammary Paget disease.
    Perrotto J; Abbott JJ; Ceilley RI; Ahmed I
    Am J Dermatopathol; 2010 Apr; 32(2):137-43. PubMed ID: 20051815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Factors of Extramammary Paget's Disease.
    Hatta N
    Curr Treat Options Oncol; 2018 Aug; 19(10):47. PubMed ID: 30112691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
    Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
    Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High preoperative and postoperative levels of carcinoembryonic antigen and CYFRA 21-1 indicate poor prognosis in patients with pathological Stage I nonsmall cell lung cancer.
    Duan X; Cui Y; Li H; Shi G; Wu B; Liu M; Chang D; Wang T; Kong Y
    Indian J Cancer; 2015 Dec; 52 Suppl 3():E158-63. PubMed ID: 27453414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of laminin-5 gamma 2 chain predicts invasion of extramammary Paget's disease cell.
    Tohmatsu Y; Imura J; Sakai T; Takagi K; Minamisaka T; Tanaka S; Noguchi A; Nakajima T; Nagata T; Makino T; Shimizu T; Fujii T
    APMIS; 2021 Jan; 129(1):3-8. PubMed ID: 32996218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical and fluorescence in situ hybridization studies on noninvasive and invasive extramammary Paget's disease.
    Hikita T; Ohtsuki Y; Maeda T; Furihata M
    Int J Surg Pathol; 2012 Oct; 20(5):441-8. PubMed ID: 23001873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo reflectance confocal microscopy of extramammary Paget disease: diagnostic evaluation and surgical management.
    Pan ZY; Liang J; Zhang QA; Lin JR; Zheng ZZ
    J Am Acad Dermatol; 2012 Feb; 66(2):e47-53. PubMed ID: 21620517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human epidermal growth factor receptor 2 protein overexpression and gene amplification in extramammary Paget disease.
    Tanaka R; Sasajima Y; Tsuda H; Namikawa K; Tsutsumida A; Otsuka F; Yamazaki N
    Br J Dermatol; 2013 Jun; 168(6):1259-66. PubMed ID: 23360223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extramammary Paget disease. Part I. epidemiology, pathogenesis, clinical features, and diagnosis.
    Shah RR; Shah K; Wilson BN; Tchack M; Busam KJ; Moy A; Leitao MM; Cordova M; Neumann NM; Smogorzewski J; Nguyen KA; Hosein S; Dafinone M; Schwartz RA; Rossi A
    J Am Acad Dermatol; 2024 Sep; 91(3):409-418. PubMed ID: 38704032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Handheld Reflectance Confocal Microscopy for the Detection of Recurrent Extramammary Paget Disease.
    Yélamos O; Hibler BP; Cordova M; Hollmann TJ; Kose K; Marchetti MA; Myskowski PL; Pulitzer MP; Rajadhyaksha M; Rossi AM; Jain M
    JAMA Dermatol; 2017 Jul; 153(7):689-693. PubMed ID: 28492924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.